Newsbenzinga
Wall Street May Be Mispricing Medtronic, Analyst Says
· Published
Article summary
BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerating organic growth. Read more.
An excerpt from the original article.
Comments —
Loading comments…